Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.045
-0.025 (-2.34%)
Nov 21, 2024, 4:00 PM EST - Market closed
Indaptus Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 7.38 | 13.36 | 9.63 | 39.13 | 1.64 | 3.8 |
Short-Term Investments | - | - | 16.81 | - | - | - |
Cash & Short-Term Investments | 7.38 | 13.36 | 26.43 | 39.13 | 1.64 | 3.8 |
Cash Growth | -53.77% | -49.45% | -32.45% | 2289.75% | -56.90% | - |
Other Receivables | - | - | - | 0.02 | - | - |
Receivables | - | - | - | 0.02 | - | - |
Prepaid Expenses | 0.25 | 0.62 | 0.73 | 0.96 | 0.01 | 0.06 |
Other Current Assets | - | 0.02 | 0.08 | 0.28 | 0.08 | 0.04 |
Total Current Assets | 7.63 | 14 | 27.24 | 40.39 | 1.73 | 3.9 |
Property, Plant & Equipment | 0.11 | 0.17 | 0.08 | 0.17 | 0 | 0 |
Other Long-Term Assets | 0.5 | 0.75 | 0.74 | 0.02 | 0.04 | 0.05 |
Accounts Payable | 2.13 | 0.81 | 1.38 | 2.54 | 0.16 | 0.03 |
Accrued Expenses | - | 1.87 | 1.97 | 1.97 | 0.24 | 0.46 |
Current Portion of Leases | 0.1 | 0.1 | 0.08 | 0.1 | - | - |
Other Current Liabilities | - | - | - | - | 1.62 | 0.25 |
Total Current Liabilities | 2.23 | 2.77 | 3.43 | 4.6 | 2.02 | 0.73 |
Long-Term Leases | 0 | 0.07 | - | 0.07 | - | - |
Common Stock | 0.1 | 0.08 | 0.08 | 0.08 | 0.02 | 0 |
Additional Paid-In Capital | 62.21 | 57.41 | 54.44 | 51.49 | 7.69 | 7.58 |
Retained Earnings | -56.31 | -45.42 | -29.99 | -15.67 | -7.96 | -4.38 |
Comprehensive Income & Other | - | - | 0.1 | - | - | - |
Total Common Equity | 6 | 12.08 | 24.63 | 35.9 | -0.25 | 3.21 |
Total Liabilities & Equity | 8.24 | 14.92 | 28.06 | 40.58 | 1.78 | 3.94 |
Total Debt | 0.11 | 0.18 | 0.08 | 0.17 | - | - |
Net Cash (Debt) | 7.27 | 13.19 | 26.35 | 38.96 | 1.64 | 3.8 |
Net Cash Growth | -53.88% | -49.96% | -32.37% | 2279.41% | -56.90% | - |
Net Cash Per Share | 0.83 | 1.57 | 3.19 | 9.52 | 0.84 | 5.19 |
Filing Date Shares Outstanding | 10.2 | 8.54 | 8.4 | 8.26 | 0.73 | 0.73 |
Total Common Shares Outstanding | 10.2 | 8.4 | 8.4 | 8.26 | 0.73 | 0.73 |
Working Capital | 5.4 | 11.22 | 23.81 | 35.78 | -0.28 | 3.16 |
Book Value Per Share | 0.59 | 1.44 | 2.93 | 4.35 | -0.34 | 4.38 |
Tangible Book Value | 6 | 12.08 | 24.63 | 35.9 | -0.25 | 3.21 |
Tangible Book Value Per Share | 0.59 | 1.44 | 2.93 | 4.35 | -0.34 | 4.38 |
Source: S&P Capital IQ. Standard template.
Financial Sources.